New method revolutionizes decision-making for drug benefit-risk analysis!
A new method called SMAA-TOPSIS was developed by combining two existing methods, SMAA and TOPSIS, to help make decisions when there are many factors to consider. This method was tested on drug benefit-risk analysis and machine gun selection. The researchers found that SMAA-TOPSIS can handle uncertain information and give clearer results compared to using SMAA alone.